Last reviewed · How we verify

NCT07424638

Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain

Recruiting now NA Last updated 24 February 2026
What this trial tests

NA trial testing Interscalene block in Interscalene Block in 75 participants. Currently enrolling.

Timeline
21 February 2026
Primary endpoint
30 July 2026
30 July 2026

Quick facts

Lead sponsorNational Cancer Institute, Egypt
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment75
Start date21 February 2026
Primary completion30 July 2026
Estimated completion30 July 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

National Cancer Institute, Egypt

Who can join

Adults 18 to 65, any sex, with Interscalene Block or Anterior Suprascapular Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare the frequency of occurrence of ipsilateral shoulder pain in patients undergoing thoracotomy with ultrasound-guided interscalene block, anterior suprascapular block as adjunct to epidural and epidural block only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Interscalene block

Trials testing the same drug.

Other recruiting trials for Interscalene Block

Currently open trials in the same condition.

Other National Cancer Institute, Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07424638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing